freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

New method of delivering chemo extends life of ovarian cancer patients by 3 years

Published on 06/03/2013

A new method of delivering chemotherapy to ovarian cancer patients has been shown to significantly increase survival time, and may one day become available to NHS and health insurance patients across the UK.

Researchers have found that giving chemo drugs via direct injections into the abdomen can raise average survival times of women with a particular type of ovarian cancer from four to seven years.

Cancer of the ovary is the fifth most common cancer among women, and can affect women of any age. As the symptoms of ovarian cancer are vague it is often not diagnosed until the advanced stages, with a third only discovered as a result of a medical emergency.

According to the charity Target Ovarian Cancer, there has been no new life-extending treatment for ovarian cancer in over 20 years. If proven, the new research would be a major advance in the treatment of the disease.

Researchers from Pittsburgh University looked at survival rates in 400 patients, some of which who had a particular type of gene mutation making them more susceptible to ovarian cancer.

Half of the patients were given chemotherapy intravenously, and the other half was given chemotherapy using the new method via injection into the abdomen. Study leader Dr Thomas Krivak explained:

“It reaches the cancerous cells in a higher concentration than when it’s administered into a vein. This means that it can work more effectively.”

Writing in the British Medical Journal, the team found that the women with low levels of a particular protein called BRCA1 benefitted from the new method. The women given chemotherapy intravenously survived four years from diagnosis on average, whilst those given the abdominal injection survived for seven years.

However, among the women with normal or high levels of the BRCA1 protein, there was not a statistically significant difference between the two methods.

Dr Krivak said: “This type of administration of chemotherapy seems to have the greatest improvement in outcomes for women who have low levels of the BRCA1 protein.”

Scientists say that the study supports the testing of ovarian cancer patients for their BRCA1 status in the future. Dr Simon Mewman, head of research at Target Ovarian Cancer, said:

"The results from this clinical study are incredibly promising.”

For access to the latest medical technology, look for a health insurance policy with full cancer cover. Many policies will cover the licensed cost of drugs and procedures even if they are not approved by NICE.

© ActiveQuote Ltd. 2013

Categories:  Medical
New method of delivering chemo extends life of ovarian cancer patients by 3 yearsA new method of delivering chemotherapy to ovarian cancer patients has been shown to significantly increase survival time, and may one day b    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member

I was pleasantly surprised with the in-depth knowledge, the efficiency and the nice and polite manner of the staff - the explanations were made very clearly.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...